1.Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry. Bethesda, MD: Cystic Fibrosis Foundation; 2016.
2.Aaron SD, Stephenson AL, Cameron DW, Whitmore GA. A statistical model to predict one-year risk of death in patients with cystic fibrosis. J Clin Epidemiol. 2015;68(11):1336–45.
3.Liou TG, Elkin EP, Pasta DJ, Jacobs JR, Konstan MW, Morgan WJ, et al. Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros. 2010;9(4):250–6.
4.Vandenbranden SL, McMullen A, Schechter MS, Pasta DJ, Michaelis RL, Konstan MW, et al. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol. 2012;47(2):135–43.
5.Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Ann Epidemiol. 2013;23(12):771–7.
6.Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153(4):345–52.
7.Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N. Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher. J Cyst Fibros. 2017.
8.Flume PA, Mogayzel PJ, Jr., Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180(9):802–8.
9.Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182(5):627–32.
10.Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003;142(6):624–30.
11.Lai HJ, Shoff SM. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am J Clin Nutr. 2008;88(1):161–6.
12.Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on G, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832–9.
13.Konstan MW, Pasta DJ, Wagener JS, VanDevanter DR, Morgan WJ. BMI fails to identify poor nutritional status in stunted children with CF. J Cyst Fibros. 2017;16(1):158–60.
14.Rizopoulos D. Joint models for longitudinal and time-to-event data: with applications in R. Boca Raton: CRC Press; 2012. xiv, 261 p. p.
15.Schluchter MD, Konstan MW, Davis PB. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Stat Med. 2002;21(9):1271–87.
16.Piccorelli AV, Schluchter MD. Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis. Stat Med. 2012;31(29):3931–45.
17.Barrett J, Diggle P, Henderson R, Taylor-Robinson D. Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference. J R Stat Soc Series B Stat Methodol. 2015;77(1):131–48.
18.Rizopoulos D. The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC. Journal of Statistical Software. 2016;72(7):1–45.
19.Hickey GL, Philipson P, Jorgensen A, Kolamunnage-Dona R. Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues. BMC Med Res Methodol. 2016;16(1):117.
20.Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, et al. The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry. Ann Am Thorac Soc. 2016;13(7):1173–9.
21.Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–87.
22.Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG, Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993;15(2):75–88.
23.Szczesniak RD, Li D, Su W, Brokamp C, Pestian J, Seid M, et al. Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood. Am J Respir Crit Care Med. 2017.
24.Matloff N. Big-n versus Big-p in Big Data. In: Buhlmann P, Drineas, P., Kane, M., van der Laan, M., editor. Handbook of Big Data. Boca Raton, FL: CRC Press; 2016. p. 23–4.
25.Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006;148(2):259–64.
26.Chen Y, Wang Y. Variable selection for joint models of multivariate longitudinal measurements and event time data. Stat Med. 2017;36(24):3820–9.
27.Andrinopoulou ER, Rizopoulos D. Bayesian shrinkage approach for a joint model of longitudinal and survival outcomes assuming different association structures. Stat Med. 2016;35(26):4813–23.
28.Neuhaus JM, McCulloch CE, Boylan RD. Analysis of longitudinal data from outcome-dependent visit processes: Failure of proposed methods in realistic settings and potential improvements. Stat Med. 2018;37(29):4457–71.